Sino Biopharmaceutical (HKSE:01177) Change In Inventory : HK$0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Sino Biopharmaceutical Change In Inventory?

Sino Biopharmaceutical's change in inventory for the quarter that ended in Jun. 2024 was HK$0 Mil. It means Sino Biopharmaceutical's inventory stayed the same from Dec. 2023 to Jun. 2024 .

Sino Biopharmaceutical's change in inventory for the fiscal year that ended in Dec. 2023 was HK$148 Mil. It means Sino Biopharmaceutical's inventory declined by HK$148 Mil from Dec. 2022 to Dec. 2023 .

Sino Biopharmaceutical's Total Inventories for the quarter that ended in Jun. 2024 was HK$1,978 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Sino Biopharmaceutical's Days Inventory for the quarter that ended in Jun. 2024 was 123.90.

Inventory Turnover measures how fast the company turns over its inventory within a year. Sino Biopharmaceutical's Inventory Turnover for the quarter that ended in Jun. 2024 was 1.47.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Sino Biopharmaceutical's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.12.

Sino Biopharmaceutical Change In Inventory Historical Data

The historical data trend for Sino Biopharmaceutical's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Change In Inventory Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-500.11

-262.52

-70.38

-436.75

148.01

Sino Biopharmaceutical Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Sino Biopharmaceutical Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

Sino Biopharmaceutical (HKSE:01177) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Sino Biopharmaceutical's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	2079.174	/	3062.529	*	365 / 2
	=	123.90

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Sino Biopharmaceutical's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	3062.529	/	2079.174
	=	1.47

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Sino Biopharmaceutical's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	2079.174	/	17089.485
	=	0.12

Sino Biopharmaceutical Change In Inventory Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (HKSE:01177) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

SBHMY:USA SBMFF:USA SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2023, 37.8% of the firm's total revenue comes from five innovative drugs and five biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 33.6% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.

Executives

Tse Ping	2101 Beneficial owner
Tse Eric S Y	2101 Beneficial owner
Cheng Cheung Ling	2101 Beneficial owner
True Merit Global Limited	2101 Beneficial owner
Tse Theresa Y Y	2101 Beneficial owner
Thousand Eagles Limited	2101 Beneficial owner
France Investment (china 1) Group Limited	2101 Beneficial owner
Remarkable Industries Limited	2101 Beneficial owner
Validated Profits Limited	2101 Beneficial owner

Sino Biopharmaceutical Headlines

No Headlines